Startups

TTTTT

Our startups

Be inspired. Search our startups.

Filter
Diamond Winners
2015 Boston Diamond Winner

Biorasis is in the business of developing a miniaturized, hypodermic-injectable biosensor for reliable continuous glucose monitoring (CGM) with autonomous operation for 3-6 months that requires no user intervention. Our goal is to vastly improve the quality of life of diabetics. Our solution eliminates surgery for sensor implantation and extraction, restores active life style, enables remote care for juveniles and the elderly, enhances compliance, and saves 50-70% in annual healthcare costs.

2014 Boston Diamond Winner

What if I told you I could save one million lives every year with just refrigerator magnets and a laser pointer? For the 500 million annual infections that go undiagnosed, current malaria diagnostics are slow, expensive, inaccurate, and chemical-based, meaning they require refrigeration and clinical expertise.
But malaria parasites are magnetic. Our reusable, mechanical mechanical device offers a handheld, quantitative diagnosis for 1/10th the cost and 100x the detection level of competitors.

Gold Winners
2017 Boston Gold Winner

There is a crisis in medical imaging. Current MRI contrast agents (GBCAs) contain toxic gadolinium. GBCAs cause brain deposition of gadolinium in all patients, and pose devastating risks to renally impaired patients. Each year over 4 million very sick patients worldwide must be denied crucial diagnostic imaging, and over 30 million patients are put at risk.
Reveal solves this >$1B problem with a biocompatible gadolinium-free contrast agent that is a safe, direct substitute for GBCAs.

2016 Switzerland Gold Winner

SwissDeCode puts the power of DNA in your hands. Our DNAFoil line is the world’s 1st portable, self-administered, DNA detection kit. Revealing DNA of major contaminants, your staff confirms safety & compliance on the line. Invented at the University of Geneva. Certification label acceptance from the Swiss CTI. MC sponsors and other F&B customers are securing Right-First-Time processes with a tool simple as a home pregnancy test. Know it when and where you need it with DNAFoil.

Swissdecode.com

2015 Boston Gold Winner

Oral health affects heart disease, Alzheimer’s & diabetes and is the 2nd largest out of pocket healthcare expense: $250 BN! Yet 40% of Americans are not accessing this basic healthcare need. Sadly, this percentage is growing due to rising costs & inconvenience.
Virtudent leverages innovations in portable equipment & telehealth technologies to bring oral healthcare to the workplace for a fraction of the cost.Through Virtudent's pop-up dental clinics, high quality care is made easy & accessible.

2015 Boston Gold Winner

Globally, 2 billion people are malnourished and anemic. Health impacts range from impaired physical and cognitive development, to infant prematurity, to death– 1 million people annually. Untreated anemia in children can have lifelong impact; 178M are undiagnosed today.
Obz Design is addressing the critical challenge of anemia diagnostics with a revolutionary non-invasive device that will replace blood testing. Our solution is 50 times less expensive, 400 times faster, and safer for patients.

2014 Boston Gold Winner

Sano offers a disposable, low cost, Point-of-Care (POC) diagnostic platform with first focus on chronic wounds, quantitatively measuring wound biochemistry (enzymes called MMPs) to personalize treatment, promote faster healing, and reduce treatment costs. In parallel, Sano will trial and commercialize an early equine arthritis diagnostic for earlier revenue in Q4 2014. Six other human and vet diseases that are characterized by elevated MMPs will be evaluated sequentially thereafter.

2014 Boston Gold Winner

Annually 47 million people in the US fall victim to a water-borne infection. Current testing methods take 24 hours or more. This waiting time is too long for efficient quality control and to prevent disease outbreaks. Fluid-Screen brings the power of an entire lab into a portable device. Fluid-Screen detects bacteria in water in 30 minutes or less. The patent pending technology is based on a silicon biosensor chip developed at Yale University. We believe that Fluid-Screen will change the world.

2014 Boston Gold Winner

For many diseases whose treatment involves frequent delivery of injectable drugs (diabetes, Parkinson's, osteoporosis, etc.), using continuous infusion pumps often leads to better outcomes than multiple daily injections, resulting in healthier patients and lower healthcare costs. Existing pumps' limitations, however, inhibit their adoption. Our Evopump - a more comfortable, precise, therapeutically flexible, and lower cost pump - should significantly increase adoption, yielding better outcomes

2014 Boston Gold Winner

3Derm is a cost-effective skin imaging system that allows any user to take clinical-quality 3D images of concerning skin lesions and upload them instantly for review by a dermatologist. We implement our technology within accountable care organizations as a triage system, allowing primary care physicians to use our handheld imager in their clinics and send images via cloud to an in-network dermatologist for review - ensuring those with alarming conditions are seen as soon as possible.

Sidecar Winners
2016 Boston Sidecar Winner

Angiex is pioneering a new approach to cancer therapy: vascular targeting. Angiex is making an antibody-drug conjugate (ADC) therapy against a novel target expressed by tumor endothelial cells and by most tumor cells.

In preclinical studies, Angiex ADCs have shown an ability to regress human xenograft and mouse syngeneic tumors. If toxicity to the normal vasculature can be limited, Angiex's ADC has the potential to provide an effective treatment for all solid tumors.

2013 Boston Sidecar Winner

We offer a non-invasive solution for measuring intracranial pressure (ICP), a critical physiologic parameter that currently requires a neurosurgeon to drill a hole into the patient’s skull. Our device, RapidICP, has a patented method to noninvasively measure ICP using a portable, inexpensive ultrasound device that can be used by a trained technician. Approximately 40% of the severe traumatic brain injury patients in the US do not receive the ICP monitoring they need and RapidICP can change that.

Silver Winners
2017 Switzerland Silver Winner

10% of the world population suffers from sleep apnea. Current take-home diagnostic devices lack accuracy, reliability, or comfort, whereas the clinical overnight gold standard is costly and uncomfortable. Sleepiz is introducing the world’s first non-contact medical grade screening solution for sleep apnea. With our device, anyone to get medically tested for sleep apnea at home without having to connect any sensors or cables – you won’t even know it’s there.

2017 Mexico Silver Winner

50% of Mexicans have visual acuity problems. Yet, people roam the streets with broken glasses, outdated prescriptions, or even worse, without glasses. Why? There is a disconnection between the current offer and the huge demand. High prices, poor service, and outdated delivery to a digital generation. Our service starts with optometrists who arrive at people’s doorsteps. We offer the entire range of products, with 48hr delivery, fair prices, 9.3 NPS quality service, and an online visual profile.

2017 Boston Silver Winner

UrSure Inc. aims to prevent HIV by driving adherence to the drug, PrEP. If taken daily, PrEP is 99% effective at preventing HIV infections in non-infected individuals. Nationwide, PrEP adherence is estimated between 20 and 50%, but UrSure Inc. has driven adherence to over 70% in its HIV prevention clinic in Philadelphia through its urine tests. UrSure’s urine tests are noninvasive and painless, cheaper, more accurate, and have a faster turnaround time than alternative PrEP tests.

2016 Boston Silver Winner

QSM Diagnostics has the fastest and lowest-cost diagnostic sensor platform for identifying and monitoring common bacteria in blood, urine, sputum, or wounds. Our technology provides results in 1 minute by detecting electronic signals from unique bacteria-produced molecules with zero sample preparation. It will provide early guidance at the point-of-care to doctors and veterinarians treating infections. The instrument is battery powered and portable. Only 10 microliters of sample fluid is needed.

2016 Switzerland Silver Winner

The way we move is important to solving diseases like Parkinson's and cerebral palsy, to becoming a better athlete, from a baby's first step, to winning the Olympics. The way we move is essential to who we are. Gait Up makes and sells next generation wearable technology for motion analysis in the sports, healthcare and wellness industries. Our products include gait and running analysis, physical activity monitoring, and OEM solutions with partners. Motion analytics. Accurate. Easy to interpret.

2016 UK Silver Winner

Prostate cancer is a global socio-economic problem. A novel diagnostic approach will help to distinguish between Prostate Cancer and Benign Prostatic Hyperplasia, the most common non-cancer prostatic condition in ageing men with symptoms similar or overlapping with those of prostate cancer. The test can be regularly performed by men using a self-monitoring tool or by a GP using a bench top device. The test will monitor the wellness of the prostate, which is typically affected in cancer patients.

2014 Boston Silver Winner

Diagnostic of diseases is a 40 billion USD global market where current technologies are expensive, require specialized equipment and take several hours to produce results, affecting billions around the world mostly in developing countries. We developed a 5 minute and $1 diagnostic technology for infectious diseases that allows health data collection and analysis in real time for disease surveillance, using big data algorithms to help decision makers to create strategies for disease control.

2012 Boston Silver Winner

Current prostate cancer diagnostics are inadequate - they lack sensitivity and prognostic value. Cellanyx is offering a predictive, sensitive, and cost effective solution to inform physicians at the radical prostatectomy decision point. Cellanyx's technology will improve the diagnostic process, increasing patient quality of life - significantly reducing health care costs.

2012 Boston Silver Winner

Cancer is diagnosed today much too late: increasing sensitivity by thousand folds, Akrivis’ Z-TECT technology will allow cancer detection so early that it will be cured faster and with less toxic drugs. Z-TECT can achieve this with blood tests or medical imaging of mm-sized tumors. After selling custom reagents to repeat customers for a year, Akrivis recently signed a worldwide distribution agreement and seeks $250k to hire 2 scientists and accelerate the launch of its first products by Q1 2013

Startups
2017 Switzerland Silver Winner

10% of the world population suffers from sleep apnea. Current take-home diagnostic devices lack accuracy, reliability, or comfort, whereas the clinical overnight gold standard is costly and uncomfortable. Sleepiz is introducing the world’s first non-contact medical grade screening solution for sleep apnea. With our device, anyone to get medically tested for sleep apnea at home without having to connect any sensors or cables – you won’t even know it’s there.

2017 Boston Gold Winner

There is a crisis in medical imaging. Current MRI contrast agents (GBCAs) contain toxic gadolinium. GBCAs cause brain deposition of gadolinium in all patients, and pose devastating risks to renally impaired patients. Each year over 4 million very sick patients worldwide must be denied crucial diagnostic imaging, and over 30 million patients are put at risk.
Reveal solves this >$1B problem with a biocompatible gadolinium-free contrast agent that is a safe, direct substitute for GBCAs.

2017 Mexico Silver Winner

50% of Mexicans have visual acuity problems. Yet, people roam the streets with broken glasses, outdated prescriptions, or even worse, without glasses. Why? There is a disconnection between the current offer and the huge demand. High prices, poor service, and outdated delivery to a digital generation. Our service starts with optometrists who arrive at people’s doorsteps. We offer the entire range of products, with 48hr delivery, fair prices, 9.3 NPS quality service, and an online visual profile.

2017 Boston Silver Winner

UrSure Inc. aims to prevent HIV by driving adherence to the drug, PrEP. If taken daily, PrEP is 99% effective at preventing HIV infections in non-infected individuals. Nationwide, PrEP adherence is estimated between 20 and 50%, but UrSure Inc. has driven adherence to over 70% in its HIV prevention clinic in Philadelphia through its urine tests. UrSure’s urine tests are noninvasive and painless, cheaper, more accurate, and have a faster turnaround time than alternative PrEP tests.

2016 Boston Silver Winner

QSM Diagnostics has the fastest and lowest-cost diagnostic sensor platform for identifying and monitoring common bacteria in blood, urine, sputum, or wounds. Our technology provides results in 1 minute by detecting electronic signals from unique bacteria-produced molecules with zero sample preparation. It will provide early guidance at the point-of-care to doctors and veterinarians treating infections. The instrument is battery powered and portable. Only 10 microliters of sample fluid is needed.

2016 Boston Sidecar Winner

Angiex is pioneering a new approach to cancer therapy: vascular targeting. Angiex is making an antibody-drug conjugate (ADC) therapy against a novel target expressed by tumor endothelial cells and by most tumor cells.

In preclinical studies, Angiex ADCs have shown an ability to regress human xenograft and mouse syngeneic tumors. If toxicity to the normal vasculature can be limited, Angiex's ADC has the potential to provide an effective treatment for all solid tumors.

2016 Switzerland Gold Winner

SwissDeCode puts the power of DNA in your hands. Our DNAFoil line is the world’s 1st portable, self-administered, DNA detection kit. Revealing DNA of major contaminants, your staff confirms safety & compliance on the line. Invented at the University of Geneva. Certification label acceptance from the Swiss CTI. MC sponsors and other F&B customers are securing Right-First-Time processes with a tool simple as a home pregnancy test. Know it when and where you need it with DNAFoil.

Swissdecode.com

2016 Switzerland Silver Winner

The way we move is important to solving diseases like Parkinson's and cerebral palsy, to becoming a better athlete, from a baby's first step, to winning the Olympics. The way we move is essential to who we are. Gait Up makes and sells next generation wearable technology for motion analysis in the sports, healthcare and wellness industries. Our products include gait and running analysis, physical activity monitoring, and OEM solutions with partners. Motion analytics. Accurate. Easy to interpret.

2016 UK Silver Winner

Prostate cancer is a global socio-economic problem. A novel diagnostic approach will help to distinguish between Prostate Cancer and Benign Prostatic Hyperplasia, the most common non-cancer prostatic condition in ageing men with symptoms similar or overlapping with those of prostate cancer. The test can be regularly performed by men using a self-monitoring tool or by a GP using a bench top device. The test will monitor the wellness of the prostate, which is typically affected in cancer patients.

2015 Boston Gold Winner

Oral health affects heart disease, Alzheimer’s & diabetes and is the 2nd largest out of pocket healthcare expense: $250 BN! Yet 40% of Americans are not accessing this basic healthcare need. Sadly, this percentage is growing due to rising costs & inconvenience.
Virtudent leverages innovations in portable equipment & telehealth technologies to bring oral healthcare to the workplace for a fraction of the cost.Through Virtudent's pop-up dental clinics, high quality care is made easy & accessible.

2015 Boston Gold Winner

Globally, 2 billion people are malnourished and anemic. Health impacts range from impaired physical and cognitive development, to infant prematurity, to death– 1 million people annually. Untreated anemia in children can have lifelong impact; 178M are undiagnosed today.
Obz Design is addressing the critical challenge of anemia diagnostics with a revolutionary non-invasive device that will replace blood testing. Our solution is 50 times less expensive, 400 times faster, and safer for patients.

2015 Boston Diamond Winner

Biorasis is in the business of developing a miniaturized, hypodermic-injectable biosensor for reliable continuous glucose monitoring (CGM) with autonomous operation for 3-6 months that requires no user intervention. Our goal is to vastly improve the quality of life of diabetics. Our solution eliminates surgery for sensor implantation and extraction, restores active life style, enables remote care for juveniles and the elderly, enhances compliance, and saves 50-70% in annual healthcare costs.

2014 Boston Silver Winner

Diagnostic of diseases is a 40 billion USD global market where current technologies are expensive, require specialized equipment and take several hours to produce results, affecting billions around the world mostly in developing countries. We developed a 5 minute and $1 diagnostic technology for infectious diseases that allows health data collection and analysis in real time for disease surveillance, using big data algorithms to help decision makers to create strategies for disease control.

2014 Boston Gold Winner

Sano offers a disposable, low cost, Point-of-Care (POC) diagnostic platform with first focus on chronic wounds, quantitatively measuring wound biochemistry (enzymes called MMPs) to personalize treatment, promote faster healing, and reduce treatment costs. In parallel, Sano will trial and commercialize an early equine arthritis diagnostic for earlier revenue in Q4 2014. Six other human and vet diseases that are characterized by elevated MMPs will be evaluated sequentially thereafter.

2014 Boston Gold Winner

Annually 47 million people in the US fall victim to a water-borne infection. Current testing methods take 24 hours or more. This waiting time is too long for efficient quality control and to prevent disease outbreaks. Fluid-Screen brings the power of an entire lab into a portable device. Fluid-Screen detects bacteria in water in 30 minutes or less. The patent pending technology is based on a silicon biosensor chip developed at Yale University. We believe that Fluid-Screen will change the world.

2014 Boston Diamond Winner

What if I told you I could save one million lives every year with just refrigerator magnets and a laser pointer? For the 500 million annual infections that go undiagnosed, current malaria diagnostics are slow, expensive, inaccurate, and chemical-based, meaning they require refrigeration and clinical expertise.
But malaria parasites are magnetic. Our reusable, mechanical mechanical device offers a handheld, quantitative diagnosis for 1/10th the cost and 100x the detection level of competitors.

2014 Boston Gold Winner

For many diseases whose treatment involves frequent delivery of injectable drugs (diabetes, Parkinson's, osteoporosis, etc.), using continuous infusion pumps often leads to better outcomes than multiple daily injections, resulting in healthier patients and lower healthcare costs. Existing pumps' limitations, however, inhibit their adoption. Our Evopump - a more comfortable, precise, therapeutically flexible, and lower cost pump - should significantly increase adoption, yielding better outcomes

2014 Boston Gold Winner

3Derm is a cost-effective skin imaging system that allows any user to take clinical-quality 3D images of concerning skin lesions and upload them instantly for review by a dermatologist. We implement our technology within accountable care organizations as a triage system, allowing primary care physicians to use our handheld imager in their clinics and send images via cloud to an in-network dermatologist for review - ensuring those with alarming conditions are seen as soon as possible.

2013 Boston Sidecar Winner

We offer a non-invasive solution for measuring intracranial pressure (ICP), a critical physiologic parameter that currently requires a neurosurgeon to drill a hole into the patient’s skull. Our device, RapidICP, has a patented method to noninvasively measure ICP using a portable, inexpensive ultrasound device that can be used by a trained technician. Approximately 40% of the severe traumatic brain injury patients in the US do not receive the ICP monitoring they need and RapidICP can change that.

2012 Boston Silver Winner

Current prostate cancer diagnostics are inadequate - they lack sensitivity and prognostic value. Cellanyx is offering a predictive, sensitive, and cost effective solution to inform physicians at the radical prostatectomy decision point. Cellanyx's technology will improve the diagnostic process, increasing patient quality of life - significantly reducing health care costs.

2012 Boston Silver Winner

Cancer is diagnosed today much too late: increasing sensitivity by thousand folds, Akrivis’ Z-TECT technology will allow cancer detection so early that it will be cured faster and with less toxic drugs. Z-TECT can achieve this with blood tests or medical imaging of mm-sized tumors. After selling custom reagents to repeat customers for a year, Akrivis recently signed a worldwide distribution agreement and seeks $250k to hire 2 scientists and accelerate the launch of its first products by Q1 2013